>> 全站文章索引 >> 第6页:
  • fMRI study of language activation in schizophrenia, schizoaffective disorder and in individuals genetically at high risk - [Xiaobo Li,Craig A.Branch,Babak A.Ardekani,Hilary Bertisch,Chindo Hicks,Lynn E.DeLisi]
  • Tone duration mismatch negativity deficits predict impairment of executive function in schizophrenia - [Atsuhito Toyomaki,Ichiro Kusumi,Testsuaki Matsuyama,Yuki Kako,Koki Ito,Tsukasa Koyama]
  • Increased urinary excretion of biopyrrins, oxidative metabolites of bilirubin, in patients with schizophrenia - [Rei Yasukawa,Tsuyoshi Miyaoka,Hideaki Yasuda,Maiko Hayashida]
  • Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys - [Demyttenaere K, Bruffaerts R, Posada-Villa J, Gasquet I, Kovess V, Lepine JP]
  • Prevalence of medication treatment for attention deficit-hyperactivity disorder among elementary school children in Johnston County, North Carolina - [Rowland AS, Umbach DM, Stallone L, Naftel AJ, Bohlig EM, Sandler DP]
  • Prevalence of depression and its treatment in an elderly population: the Cache County study - [Steffens DC, Skoog I, Norton MC, Hart AD, Tschanz JT, Plassman BL, Wyse BW, Welsh-Bohmer KA, Breitne]
  • Prescription of psychotropic medications to youths in office-based practice - [Goodwin R, Gould MS, Blanco C, Olfson M]
  • Prediction of the 10-year course of borderline personality disorder - [Zanarini MC, Frankenburg FR, Hennen J, Reich DB, Silk KR]
  • Placebo response in depression: bane of research, boon to therapy - [GAVIN ANDREWS, MD]
  • Pediatric stimulant and selective serotonin reuptake inhibitor prescription trends: 1992 to 1998 - [Rushton JL, Whitmire JT]
  • Abnormal prediction error is associated with negative and depressive symptoms in schizophrenia - [P.M.Moran,L.Owen,A.E.Crookes,M.M.Al-Uzri,M.A.Reveley]
  • Brain structural changes in schizophrenia patients with persistent hallucinations - [Owen G.O]
  • Diffusion Tensor Imaging of the Superior Longitudinal Fasciculus and Working Memory in Recent-Onset Schizophrenia - [Katherine H.Karlsgodt,Theo G.M.van Erp,Russell A.Poldrack,Carrie E.Bearden,Keith H.Nuechterlein,andT]
  • Impaired facial emotion recognition and reduced amygdalar volume in schizophrenia - [Chihiro Namiki,Kazuyuki Hiraob,Makiko Yamada,Takashi Hanakawa]
  • Improvement of prefrontal brain function in schizophrenia under atypical neuroleptic treatment - [A.J. Fallgattera, M.J. Herrmanna and A.C. Ehlisa]
  • Frequency and predictive values of first rank symptoms at baseline among 362 young adult patients with first-episode schizophrenia - [Anne Thorup,Lone Petersen,Pia Jeppesen,Merete Nordentoft]
  • Outpatient psychotherapy for borderline personality disorder: randomized trial of schema-focused therapy vs transference-focused psychotherapy - [Giesen-Bloo J, van Dyck R, Spinhoven P, van Tilburg W, Dirksen C, van Asselt T, Kremers I, Nadort M]
  • New Analysis Disputes Antidepressant, Suicide Link - [Jim Rosack]
  • National survey of psychotherapy training in psychiatry, psychology, and social work - [Weissman MM, Verdeli H, Gameroff MJ, Bledsoe SE, Betts K, Mufson L, Fitterling H, Wickramaratne P]
  • Morning cortisol as a risk factor for subsequent major depressive disorder in adult women - [T.O. HARRIS, MA, S. BORSANYI, BSc, S. MESSARI, MSc, K. STANFORD, BSc and G.W. BROWN, PhD]
  • Modafinil as an alternative to methylphenidate as augmentation for depression treatment - [Xiong GL, Christopher EJ, Goebel J]
  • Methylphenidate augmentation of citalopram in elderly depressed patients - [Lavretsky H, Kumar A]
  • Medication augmentation after the failure of SSRIs for depression - [Trivedi MH, Fava M, Wisniewski SR, Thase ME, Quitkin F, Warden D, Ritz L, Nierenberg AA, Lebowitz BD]
  • Addition of memantine to antipsychotic treatment in schizophrenia inpatients with residual symptoms: A preliminary study - [Amir Krivoy,Abraham Weizman,Lucian Laor,Nurit Hellinger,Zvi Zemishlany,Tsvi Fischel]
  • Heritability of Brain Morphology Related to Schizophrenia: A Large-Scale Automated Magnetic Resonance Imaging Segmentation Study - [Aaron L.Goldman,Lukas Pezawas,Venkata S.Mattay,Bruce Fischl,Beth A.Verchinski,Brad Zoltick]
  • Altered antioxidant defense system in clinically stable patients with schizophrenia and their unaffected siblings - [Leila Ben Othmen,Anwar Mechri,Chiraz Fendri,Muriel Bost,Guy Chazot,Lotfi Gaha,Abdelhamid Kerkeni]
  • Cognition, functioning and quality of life in schizophrenia treatment: Results of a one-year randomized controlled trial of olanzapine and quetiapine - [L.P.Voruganti,A.G.Awad,G.Parker,C.Forrest,Y.Usmani,M.L.D.Fernando,S.Senthilal]
  • Clinical predictors of therapeutic response to clozapine in a sample of Turkish patients with treatment-resistant schizophrenia - [Umit B.Semiz,Mesut Cetin,Cengiz Basoglu,Servet Ebrinc,Ozcan Uzun,Hasan Herken]
  • Lost human capital from early-onset chronic depression - [Berndt ER, Koran LM, Finkelstein SN, Gelenberg AJ, Kornstein SG, Miller IM, Thase ME, Trapp GA, Kell]
  • Lithium augmentation for treatment-resistant depression in the elderly - [Lafferman J, Solomon K, Ruskin P]
  • Increasing identification of psychosocial problems 1979-1996 - [Kelleher KJ, McInerny TK, Gardner WP, Childs GE, Wasserman RC]
  • Increased methylphenidate usage for attention deficit disorder in the 1990s - [Safer DJ, Zito JM, Fine EM]
  • Impairment of social perception associated with lesions of the prefrontal cortex - [Mah L, Arnold MC, Grafman J]
  • MRI brain volume abnormalities in young, nonpsychotic relatives of schizophrenia probands are associated with subsequent prodromal symptoms - [Beng-Choon Ho]
  • Dysglycemia in a community sample of people treated for schizophrenia: The Diabetes in Schizophrenia in Central-south Ontario (DiSCO) study - [L.P.Voruganti,Z.Punthakee,R.J.VanLieshout,D. MacCrimmon,G.Parker,A.G.Awad,H.C.Gerstein]
  • Quantitative analysis of ataxic gait in patients with schizophrenia: The influence of age and visual control - [Hong Jin Jeon,Maeng Je Cho,Seong-Jin Cho,Seon-Uk Kim,Soo-Kyung Park]
  • Affect recognition in schizophrenia: impairments and treatment - [W. Woelwera and N. Frommann]
  • Neuropsychological frontal impairments and negative symptoms in schizophrenia - [Diego J.Martino,Demián Bucay,Judith T.Butman,Ricardo F.Allegri]
  • Dissociation of emotional decision-making from cognitive decision-making in chronic schizophrenia - [Yanghyun Lee,Yang-Tae Kim,Eugene Seo,Oaktae Park,Sung-Hun Jeong Sang Heon Kim,Seung-Jae Lee]
  • Familial liability and schizophrenia phenotypes: A polydiagnostic approach - [Victor Peralta,Manuel J.Cuesta]
  • Anterior and posterior cingulum abnormalities and their association with psychopathology in schizophrenia: A diffusion tensor imaging study - [Hironobu Fujiwara,Chihiro Namiki,Kazuyuki Hirao,Jun Miyata]
  • Analysis of resolution criteria in patients with schizophrenia treated with olanzapine for an acute psychotic episode - [Joseph Peuskens,Leonard Kaufman,Betty Van Vleymen]
  • Effect of buspirone, a serotonin1A partial agonist, on cognitive function in schizophrenia: A randomized, double-blind, placebo-controlled study - [Tomiki Sumiyoshi,Sohee Park ,Karu Jayathilake,Ajanta Roy]
  • Treatment of negative symptoms of schizophrenia using repetitive transcranial magnetic stimulation in a double-blind randomized controlled study - [Radovan Prikryl,Tomas Kasparek,Simona Skotakova,Libor Ustohal]
  • Testosterone for schizophrenia - [A Elias, A Kumar]
  • Antidepressants for the negative symptoms of schizophrenia - [C Rummel, W Kissling, S Leucht]
  • The effect of gender on emotion perception in schizophrenia and bipolar disorder - [A. Vaskinn1,2, K. Sundet3, S. Friis1,2, C. Simonsen2,3, A. B.]
  • The specificity of neuropsychological impairment in predicting antidepressant non-response in the very old depressed - [Joel R. Sneed 1, John G. Keilp 1, Adam M. Brickman 2, Steven P. Roose 1]
  • Measurement of quality of life in schizophrenia: a comparison of two scales - [Yvette Kusel1, Richard Laugharne2, Sian Perrington3, Jan McKendrick4]
  • The Bipolar Depression Rating Scale (BDRS): its development, validation and utility - [Michael Berka,b,c, Gin S Malhid,e,f, Catherine Cahillf,g, A Catherine Carmana,b]
  • Somatic Complaints in Children with Anxiety Disorders and their Unique Prediction of Poorer Academic Performance - [Alicia A. Hughes1, Brittany Lourea-Waddell1 and Philip C. Kendall2]
  • Interaction of dopamine system genes and cognitive functions in patients with schizophrenia - [M. V. Alfimova1, 2, 3, V. E. Golimbet1, 2, 3, I. K. Gritsenko1]
  • A caffeine challenge test in panic disorder patients, their healthy first-degree relatives, and healthy controls - [Antonio E. Nardi, M.D. 1, Alexandre M. Valença, M.D. 1, Isabella Nascimento, M.D. 1]
  • Shame, personality, and social anxiety symptoms in Chinese and American nonclinical samples: a cross-cultural study - [Jie Zhong, Ph.D. 1, Aimin Wang, Ph.D. 2, Mingyi Qian, Ph.D. 1, Lili Zhang]
  • How common is resistance to treatment in recurrent, nonpsychotic geriatric depression - [Little JT, Reynolds CF 3rd, Dew MA, Frank E, Begley AE, Miller MD, Cornes C]
  • Fluoxetine Cognitive-Behavioral Therapy and Their Combination for Adolescents With Depression - [Glass RM]
  • Establishment of Diagnostic Validity in Psychiatric Illness Its Application to Schizophrenia - [Robins E, Guze SB]
  • Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression - [Tohen M, Vieta E, Calabrese J, Ketter TA, Sachs G, Bowden C, Mitchell PB, Centorrino F]
  • Efficacy of duloxetine on cognition, depression, and pain in elderly patients with major depressive disorder - [Raskin J, Wiltse CG, Siegal A, Sheikh J, Xu J, Dinkel JJ, Rotz BT, Mohs RC]
  • Duloxetine for the Treatment of Major Depressive Disorder in Older Patients - [Nelson JC, Wohlreich MM, Mallinckrodt CH, Detke MJ, Watkin JG, Kennedy JS]
  • Distributed disturbances in brain structure and function in schizophrenia - [Lewis DA]
  • Depressive symptoms and cognitive decline in elderly people. Longitudinal study - [Paterniti S, Verdier-Taillefer MH, Dufouil C, Alpérovitch A.]
  • Early Evidence on the Effects of Regulators Suicidality Warnings on SSRI Prescriptions and Suicide in Children and Adolescents - [Gibbons RD, Brown CH, Hur K, Marcus SM, Bhaumik DK, Erkens JA, Herings RM, Mann JJ]
  • Intensive psychosocial intervention enhances functioning in patients with bipolar depression - [Miklowitz DJ, Otto MW, Frank E, Reilly-Harrington NA, Kogan JN, Sachs GS, Thase ME]
  • Acute psychosis leads to increased QT variability in patients suffering from schizophrenia - [Bär KJ, Koschke M, Boettger MK, Berger S, Kabisch A, Sauer H, Voss A, Yeragani VK]
  • Reaction time and sustained attention in schizophrenia and its genetic predisposition - [Birkett P, Sigmundsson T, Sharma T, Toulopoulou T, Griffiths TD, Reveley A, Murray R]
  • Working memory in siblings of schizophrenia patients - [Neus Barrantes-Vidal,Mari Aguilera,Sílvia Campanera,Mar Fatjó-Vilas]
  • Empirical validation of competing definitions of schizophrenia - [Manuel J.Cuesta,Victor Peralta,Amalia Zarzuela]
  • Prepulse inhibition of acoustic startle in Japanese patients with chronic schizophrenia - [Kunugi H, Tanaka M,Hori H]
  • Schizophrenia patients show impaired response switching in saccade tasks - [Cosima Franke a,b,*,Benedikt Reuter a,Lisa Schulz a,b,Norbert Kathmann a]
  • Suicide schema in schizophrenia The effect of emotional reactivity negative symptoms and schema elaboration - [Nicholas Tarrier a,Patricia Gooding a,Lynsey Gregg,Judith Johnson a]
  • Assessment of motivation to change substance use in dually-diagnosed schizophrenia patients - [Joanna E.Strong Kinnaman,Alan S.Bellack,Clayton H.Brown,Ye Yang]
  • Decline in Treatment of Pediatric Depression After FDA Advisory on Risk of Suicidality With SSRIs - [Libby AM, Brent DA, Morrato EH, Orton HD, Allen R, Valuck RJ]
  • Comparison of Sertraline and Nortriptyline in the Treatment of Major Depressive Disorder in Late Life - [Bondareff W, Alpert M, Friedhoff AJ, Richter EM, Clary CM, Batzar E]
  • Cognitive deficits in depression - [MARIE-PAULE AUSTIN, MD]
  • Clinical Features of Bipolar Depression Versus Major Depressive Disorder in Large Multicenter Trials - [Perlis RH, Brown E, Baker RW, Nierenberg AA.]
  • Childhood Sibling Relationships as a Predictor of Major Depression in Adulthood - [Robert J. Waldinger, M.D., George E. Vaillant, M.D. and E. John Orav, Ph.D.]
  • Impaired recognition and expression of emotional prosody in schizophrenia Review and meta-analysis - [Marjolijn Hoekert a,René S.Kahn b,Marieke Pijnenborg a,c,André Alemana]
  • Contrast sensitivity and magnocellular functioning in schizophrenia - [Bernt C.Skottun a,John R.Skoyles b,c,*]
  • Verification of proposed peripheral biomarkers in mononuclear cells of individuals with schizophrenia - [Yuanrong Yao,Johannes Schroder,Ha˚kan Karlsson]
  • The complexity of using D2-dopamine antagonists in the treatment of patients with schizophrenia - [F.-A.Wiesel,L.Bjerkenstedt,G.Edman,L.Flyckt]
  • Delayed sympathetic hyperactivity is induced by ECT in patients with schizophrenia - [Tatsuro Kuwahara,Aihide Yoshino,Soichiro Nomura]
  • Childhood adversities and psychosocial disorders - [Maughan B, McCarthy G.]
  • Changes in Cognitive Functioning Following Treatment of Late-Life Depression - [Butters MA, Becker JT, Nebes RD, Zmuda MD, Mulsant BH, Pollock BG, Reynolds CF 3rd]
  • Association between youth-focused firearm laws and youth suicides - [Webster DW, Vernick JS, Zeoli AM, Manganello JA]
  • Antidepressants and Pediatric Depression The Risk of Doing Nothing - [Brent DA]
  • Antidepressant Prescribing Practices of Outpatient Psychiatrists - [Olfson M, Marcus SC, Pincus HA, Zito JM, Thompson JW, Zarin DA.]
  • Amisulpride versus risperidone in the treatment of depression in patients with schizophrenia： A randomized, open-label, controlled trial - [Sung-Wan Kim a,b,Il-Seon Shin a,b,Jae-Min Kim a,b,Seung-Hyun Lee c]
  • The effectiveness of ziprasidone in treating impaired quality of life in schizophrenia - [Michael S.Ritsner a,b,Vladimir Yorkov a,Yael Ratner a,Peter Soifer a,Anatoly Gibel a]
  • Effectiveness, safety, and tolerability of ziprasidone for treating schizophrenia patients undergoing usual care - [Yael Ratner a,Anatoly Gibel a,Vladimir Yorkova,Michael S.Ritsnera,b]
  • Increased cerebellar vermis white-matter volume in men with schizophrenia - [Kwang-Hyuk Lee a,*,Tom F.D.Farrow a,Randolph W.Parks a,Lisa D.Newton a]
  • Psychiatric syndromes comorbid with mental retardation： Differences in cognitive and adaptive skills - [Santo F.Di Nuovoa,*,Serafino Buono b]
  • Disturbed frontal gyrification within families affected with schizophrenia - [Peter Falkaia,*,William G.Honer b,Thomas Kamer j,Simone Dustert]
  • Self-assessment of functional status in schizophrenia - [Christopher R.Bowie*,Elizabeth W.Twamley,Hannah Anderson,Brooke Halpern,Thomas L.Patterson,Philip D.]
  • Serum BDNF levels and weight gain in schizophrenic patients on long-term treatment with antipsychotics - [Xiang Yang Zhanga,Yun Long Tan,Dong Feng Zhou,Lian Yuan Cao,Gui Ying Wu,Qi Xu,Yan Shen,Colin N.Haile]
  • A randomized, double-blind, placebo-controlled, study of the efficacy and safety of aripiprazole 10 - [Joseph P.McEvoya,David G.Daniel b,William H.Carson Jr.c,Robert D.McQuade c,Ronald N.Marcusd]
  • Antidepressant pharmacotherapy in the treatment of depression in the very old： a randomized placebo-controlled trial - [Roose SP, Sackeim HA, Krishnan KR, Pollock BG, Alexopoulos G, Lavretsky H, Katz IR, Hakkarainen H; O]
  • Antidepressant drug therapy and suicide in severely depressed children and adults - [Olfson M, Marcus SC, Shaffer D]
  • Aging and clinical pharmacology: implications for antidepressants - [Lotrich FE, Pollock BG]
  • Age effects on antidepressant-induced manic conversion - [Martin A, Young C, Leckman JF, Mukonoweshuro C, Rosenheck R, Leslie D.]


    • 分页: 1 2 3 4 5 [6] 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40
    41 42 43 44 45 46 47 48 49 50